1. Medicine

A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study

  1. Joachim Linssen
  2. Anthony Ermens
  3. Marvin Berrevoets
  4. Michela Seghezzi
  5. Giulia Previtali
  6. Simone van der Sar-van der Brugge
  7. Henk Russcher
  8. Annelies Verbon
  9. Judith MEP Gillis
  10. Jürgen Riedl
  11. Eva de Jongh
  12. Jarob Saker
  13. Marion Münster
  14. Imke CA Munnix
  15. Anthonius Dofferhof
  16. Volkher Scharnhorst
  17. Heidi Ammerlaan
  18. Kathleen Deiteren
  19. Stephan JL Bakker
  20. Lucas Joost Van Pelt
  21. Yvette Kluiters-de Hingh
  22. Mathie PG Leers
  23. Andre J van der Ven  Is a corresponding author
  1. Sysmex Europe GMBH, Germany
  2. Amphia Hospital, Netherlands
  3. Elisabeth-Tweesteden Hospital, Netherlands
  4. Hospital Papa Giovanni XXIII Bergamo, Italy
  5. Erasmus MC, University Medical Center, Netherlands
  6. Leiden University Medical Center, Netherlands
  7. Albert Schweitzer Hospital, Netherlands
  8. Canisius Wilhelmina Hospital, Netherlands
  9. Catharina Hospital, Netherlands
  10. University Hospital Antwerp, Belgium
  11. University Medical Center Groningen, University of Groningen, Netherlands
  12. Zuyderland Medical Center, Netherlands
  13. Radboud University Medical Center, Netherlands
https://doi.org/10.7554/eLife.63195
Share this article
Cite this article
  1. Joachim Linssen
  2. Anthony Ermens
  3. Marvin Berrevoets
  4. Michela Seghezzi
  5. Giulia Previtali
  6. Simone van der Sar-van der Brugge
  7. Henk Russcher
  8. Annelies Verbon
  9. Judith MEP Gillis
  10. Jürgen Riedl
  11. Eva de Jongh
  12. Jarob Saker
  13. Marion Münster
  14. Imke CA Munnix
  15. Anthonius Dofferhof
  16. Volkher Scharnhorst
  17. Heidi Ammerlaan
  18. Kathleen Deiteren
  19. Stephan JL Bakker
  20. Lucas Joost Van Pelt
  21. Yvette Kluiters-de Hingh
  22. Mathie PG Leers
  23. Andre J van der Ven
(2020)
A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study
eLife 9:e63195.
https://doi.org/10.7554/eLife.63195
  2. Download BibTeX
  3. Download .RIS

Peer review process

This article was accepted for publication via eLife's original publishing model. eLife publishes the authors' accepted manuscript as a PDF only version before the full Version of Record is ready for publication. Peer reviews are published along with the Version of Record.

History

  1. Version of Record published
  2. Accepted Manuscript published
  3. Accepted
  4. Received

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Joachim Linssen
  2. Anthony Ermens
  3. Marvin Berrevoets
  4. Michela Seghezzi
  5. Giulia Previtali
  6. Simone van der Sar-van der Brugge
  7. Henk Russcher
  8. Annelies Verbon
  9. Judith MEP Gillis
  10. Jürgen Riedl
  11. Eva de Jongh
  12. Jarob Saker
  13. Marion Münster
  14. Imke CA Munnix
  15. Anthonius Dofferhof
  16. Volkher Scharnhorst
  17. Heidi Ammerlaan
  18. Kathleen Deiteren
  19. Stephan JL Bakker
  20. Lucas Joost Van Pelt
  21. Yvette Kluiters-de Hingh
  22. Mathie PG Leers
  23. Andre J van der Ven
(2020)
A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study
eLife 9:e63195.
https://doi.org/10.7554/eLife.63195

Share this article

https://doi.org/10.7554/eLife.63195